ScripThe biopharmaceutical industry has been so good at forming new companies that it's created a looming leadership challenge: as today's CEOs and board members near retirement age, there aren't enough ex
ScripWomen increasingly are being appointed to biopharma leadership roles, but while there is some progress in terms of gender diversity, racial diversity also is a concern. Parts 1 and 2 of Scrip 's Work
Scripart 1 of Scrip 's Workforce Roundtable discussed the importance of creating an attractive company culture, including flexible working hours, and keeping an open mind about qualifications required whe
ScripAs companies flurried to clinch deals by the end of the year, a number of significant agreements were signed or completed last December. Notable among them were Amgen's $415 million deal to buy Icelan